• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声心动图评估肝硬化患者左心室功能:与全身血液动力学和肾功能障碍的关系。

LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.

机构信息

Liver Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalunya, Spain.

出版信息

J Hepatol. 2013 Jan;58(1):51-7. doi: 10.1016/j.jhep.2012.08.027. Epub 2012 Sep 16.

DOI:10.1016/j.jhep.2012.08.027
PMID:22989573
Abstract

BACKGROUND & AIMS: The current study aimed at assessing the potential role of cardiac abnormalities in the pathogenesis of circulatory and renal dysfunction in cirrhosis.

METHODS

One hundred and fifty-two patients (34 without ascites, 95 with ascites without renal failure and 21 with hepatorenal syndrome) were evaluated using Doppler echocardiography. In 102 patients, diastolic function was assessed by measuring parameters related to ventricular filling velocity, mitral annulus velocity and left atrial dimensions. Cardiopulmonary pressures were also measured by cardiac catheterization in 54 patients. In 50 additional patients, left ventricular myocardial strain was performed to estimate myocardial contractility and systolic function.

RESULTS

Grade 1 and 2 diastolic dysfunction was present in 41% and 16% of the patients, respectively. There was no patient with severe grade 3 diastolic dysfunction. Grade 2 diastolic dysfunction was associated with higher cardiopulmonary pressures but values were within the normal limits in all cases. Diastolic dysfunction directly correlated with liver failure but not with the degree of impairment in circulatory and renal function. The proportion of patients without or with grade 1 or 2 diastolic dysfunction was similar in patients with compensated cirrhosis, with ascites without renal failure or with hepatorenal syndrome despite marked differences in the degree of circulatory dysfunction, as indicated by plasma renin activity and noradrenaline concentration. The heart rate and systolic function were normal in all cases. There were no differences between patients without ascites, with ascites without renal failure or with HRS, despite marked differences in the activity of the renin-angiotensin system and sympathetic nervous system. These features indicate an impaired response of cardiac chronotropic and inotropic function to changes in systemic hemodynamics.

CONCLUSIONS

These data indicates that: (1) diastolic dysfunction is frequent in cirrhosis but in most cases it is of mild degree and does not increase the cardiopulmonary pressure to abnormal levels. This feature, which may be due to the central hypovolemia of cirrhosis, probably accounts for the lack of symptoms associated with this condition. (2) Diastolic dysfunction in cirrhosis is unrelated to circulatory dysfunction, ascites and HRS. (3) In cirrhosis, there is a lack of response of the left ventricular systolic and chronotropic function to peripheral arterial vasodilation and activation of the sympathetic nervous system and this feature is an important contributory factor to the progression of circulatory dysfunction and the pathogenesis of ascites and HRS.

摘要

背景与目的

本研究旨在评估心脏异常在肝硬化患者循环和肾功能障碍发病机制中的潜在作用。

方法

对 152 名患者(34 名无腹水,95 名无肾功能衰竭性腹水,21 名肝肾综合征)进行多普勒超声心动图评估。在 102 名患者中,通过测量与心室充盈速度、二尖瓣环速度和左心房大小相关的参数评估舒张功能。在 54 名患者中还通过心导管测量心肺压力。在另外 50 名患者中,进行左心室心肌应变以评估心肌收缩力和收缩功能。

结果

41%和 16%的患者分别存在 1 级和 2 级舒张功能障碍。无严重 3 级舒张功能障碍患者。2 级舒张功能障碍与较高的心肺压力相关,但所有病例均在正常范围内。舒张功能障碍与肝功能衰竭直接相关,但与循环和肾功能障碍的严重程度无关。在代偿性肝硬化、无腹水性肾功能衰竭或肝肾综合征患者中,无舒张功能障碍或 1 级或 2 级舒张功能障碍的患者比例相似,尽管循环功能障碍的程度存在明显差异,表现为血浆肾素活性和去甲肾上腺素浓度升高。所有病例的心率和收缩功能均正常。无腹水、无腹水性肾功能衰竭或 HRS 患者之间无差异,尽管肾素-血管紧张素系统和交感神经系统的活性存在明显差异。这些特征表明心脏变时和变力功能对全身血液动力学变化的反应受损。

结论

这些数据表明:(1)肝硬化患者舒张功能障碍常见,但大多数为轻度且不会将心肺压力增加到异常水平。这种特征可能是由于肝硬化的中心性低血容量所致,可能是与该疾病相关的无症状原因。(2)肝硬化患者的舒张功能障碍与循环功能障碍、腹水和 HRS 无关。(3)肝硬化患者左心室收缩和变时功能对周围动脉扩张和交感神经系统激活无反应,这一特征是循环功能障碍进展和腹水及 HRS 发病机制的重要促成因素。

相似文献

1
LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.超声心动图评估肝硬化患者左心室功能:与全身血液动力学和肾功能障碍的关系。
J Hepatol. 2013 Jan;58(1):51-7. doi: 10.1016/j.jhep.2012.08.027. Epub 2012 Sep 16.
2
Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine.舒张功能障碍是肝硬化、门静脉高压和肌酐正常患者预后不良的预测指标。
Hepatology. 2013 Nov;58(5):1732-41. doi: 10.1002/hep.26509. Epub 2013 Sep 30.
3
Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites.肝硬化伴腹水患者左心室舒张功能障碍与炎症活动、肾功能障碍和肝相关死亡率的关系。
Eur J Gastroenterol Hepatol. 2024 Jun 1;36(6):775-783. doi: 10.1097/MEG.0000000000002762. Epub 2024 Mar 19.
4
Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.口服α-肾上腺素能激动剂米多君对肝硬化腹水患者肾血流动力学和肾功能的急性影响。
Hepatology. 1998 Oct;28(4):937-43. doi: 10.1002/hep.510280407.
5
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.低剂量心房利钠肽在代偿期肝硬化中的心血管和肾脏效应
Am J Gastroenterol. 1997 May;92(5):852-7.
6
Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis.心脏结构和功能异常在肝硬化高动力循环和肾钠潴留发病机制中的作用
Clin Sci (Lond). 1999 Sep;97(3):259-67.
7
Hepatorenal syndrome.肝肾综合征
Forum (Genova). 1998 Jan-Mar;8(1):62-81.
8
Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.肝硬化腹水及肝肾综合征的发病因素与临床要素
Ann Ital Med Int. 1999 Oct-Dec;14(4):264-84.
9
Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.白蛋白扩容联合腹腔穿刺术对伴有严重腹水和肝肾综合征的重症肝硬化患者血流动力学及肾功能的影响:一项前瞻性非对照试验
Crit Care. 2008;12(1):R4. doi: 10.1186/cc6765. Epub 2008 Jan 15.
10
Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.分子吸附再循环系统在治疗肝硬化伴腹水且血管收缩剂治疗失败的 1 型肝肾综合征患者方面无效。
Gut. 2010 Mar;59(3):381-6. doi: 10.1136/gut.2008.174615. Epub 2009 Aug 25.

引用本文的文献

1
Cardiac Remodeling and Arrhythmic Burden in Pre-Transplant Cirrhotic Patients: Pathophysiological Mechanisms and Management Strategies.移植前肝硬化患者的心脏重塑与心律失常负担:病理生理机制与管理策略
Biomedicines. 2025 Mar 28;13(4):812. doi: 10.3390/biomedicines13040812.
2
Effects of Transjugular Intrahepatic Portosystemic Shunt on Renal and Pulmonary Function in Hepatic Decompensation with and without Hepatorenal and Hepatopulmonary Syndromes: A Review.经颈静脉肝内门体分流术对伴有和不伴有肝肾综合征及肝肺综合征的肝失代偿患者肾脏和肺功能的影响:一项综述
J Clin Transl Hepatol. 2024 Sep 28;12(9):780-791. doi: 10.14218/JCTH.2024.00188. Epub 2024 Jul 25.
3
Evaluating Diastolic Dysfunction as an Indicator of Cirrhotic Cardiomyopathy in Decompensated Chronic Liver Disease.
评估舒张功能障碍作为失代偿期慢性肝病中肝硬化心肌病指标的作用
Cureus. 2024 Jun 28;16(6):e63388. doi: 10.7759/cureus.63388. eCollection 2024 Jun.
4
The Contemporary Role of Speckle Tracking Echocardiography in Cirrhotic Cardiomyopathy.斑点追踪超声心动图在肝硬化性心肌病中的当代作用
Life (Basel). 2024 Jan 25;14(2):179. doi: 10.3390/life14020179.
5
From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury.从过去到现在再到未来:特利加压素与肝肾综合征 - 急性肾损伤
Hepatology. 2025 Jun 1;81(6):1878-1897. doi: 10.1097/HEP.0000000000000790. Epub 2024 Feb 14.
6
How non-alcoholic fatty liver disease and cirrhosis affect the heart.非酒精性脂肪性肝病和肝硬化如何影响心脏。
Hepatol Int. 2023 Dec;17(6):1333-1349. doi: 10.1007/s12072-023-10590-1. Epub 2023 Sep 28.
7
Hepatorenal syndrome: Current concepts and future perspectives.肝肾综合征:当前概念与未来展望。
Clin Mol Hepatol. 2023 Oct;29(4):891-908. doi: 10.3350/cmh.2023.0024. Epub 2023 Apr 13.
8
Is Cirrhotic Cardiomyopathy Related to Cirrhosis Severity?肝硬化性心肌病与肝硬化严重程度有关吗?
Rambam Maimonides Med J. 2023 Jan 29;14(1):e0001. doi: 10.5041/RMMJ.10488.
9
Cirrhotic Cardiomyopathy: The Interplay Between Liver and Heart.肝硬化性心肌病:肝脏与心脏之间的相互作用
Cureus. 2022 Aug 13;14(8):e27969. doi: 10.7759/cureus.27969. eCollection 2022 Aug.
10
Cardiac risk stratification of the liver transplant candidate: A comprehensive review.肝移植候选者的心脏风险分层:一项全面综述。
World J Transplant. 2022 Jul 18;12(7):142-156. doi: 10.5500/wjt.v12.i7.142.